In today's medical field, research on neuroprotection technology is on the rise. Since diseases of the central nervous system share common neurodegenerative mechanisms, research on how to reduce neuron loss has attracted much attention. Whether it is stroke, traumatic brain injury or neurodegenerative diseases, neuroprotective strategies have become a key to preventing or delaying the progression of the disease.
The core of neuroprotection is to prevent or delay the process of nerve cell death, and many damage mechanisms are similar in different pathologies, such as insufficient oxygen and glucose supply, energy imbalance, and oxidative stress.
Behind the loss of neurons, these seemingly invisible mechanisms are affecting the health of nerve cells. Of these, excitotoxicity and oxidative stress are the two factors of greatest concern, and many neuroprotective treatment options target these two mechanisms.
Excitotoxicity is an important mechanism in many central nervous system diseases. Overactivation of glutamate receptors, especially NMDA receptors, can cause calcium ions to enter the interior of neurons, ultimately triggering cell death. An effective way to control excitotoxicity is to use glutamate antagonists.
The main purpose of glutamate antagonists is to inhibit the binding of glutamate to NMDA receptors, reduce calcium accumulation, and thus avoid the development of excitotoxicity.
Although various glutamate antagonists have made certain clinical progress, many still face the challenge of insufficient effectiveness or intolerable side effects. Recent research shows that some emerging treatments, such as estrogen and growth factors, may become more promising options.
Oxidative stress plays an important role in neuronal apoptosis, which is often caused by neuroinflammation. Various neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are associated with significant increases in oxidative stress.
The use of antioxidants, especially in neurodegenerative diseases, controls oxidative stress precisely by eliminating reactive oxygen species.
In the search for antioxidants, effective drugs include acetylcysteine, sphingosine and various vitamins. Research on these antioxidants is not limited to specific diseases, but also shows different effects on different patient groups (such as age, gender, etc.).
Whether it is through drugs or other means, exercise, as a non-drug intervention strategy, also has good prospects for promoting neuroprotection. Exercise is thought to enhance neuronal survival and improve overall brain health.
Today, intensive research into neuroprotection is underway to identify various interventions that can prevent or slow down neurodegenerative diseases. This includes not only traditional drug interventions, but also emerging nutrients, hormones, and even new small molecule treatments, which may become new treatment options in the future.
With the advancement of science and technology, can we better understand these mysterious neuroprotective mechanisms? What kind of innovative treatments will emerge in the future to protect fragile neural networks?